Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis ...

National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of 0.5ML Autodisable Syringes manufactured by Afrimedical Manufacturing and Supplies Limited, Ibafo, Ogun ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Thus the 1.0 mL label contributes to Patient Blood Management. The safePICO blood gas syringe is already barcoded, helping you match the sample with the correct patient. With the FLEXLINK data ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...

Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...

or all four footpads using different colors of tattoo paste or ink with a 27-gauge hypodermic needle attached to a 1-ml tuberculin syringe. After placing the foot to be marked with palmar or ...